![]() |
市场调查报告书
商品编码
1426961
骨骼和关节保健补充剂市场规模 - 按产品(维生素和矿物质、胶原蛋白)、形式(胶囊和片剂、粉末)、消费者(老年人、成人、孕妇)、配销通路(药房、电子商务)和全球预测(2024-2032)Bone & Joint Health Supplements Market Size - By Product (Vitamin & Minerals, Collagen), Form (Capsule & Tablets, Powders), Consumer (Geriatric, Adults, Pregnant Women), Distribution Channel (Pharmacies, E-commerce), & Global Forecast (2024-2032) |
在人口老化的推动下,骨关节保健品产业预计从 2024 年到 2032 年将以 7.5% 的CAGR成长。骨质疏鬆症和关节炎等骨骼和关节相关问题的盛行率不断上升。根据《柳叶刀》的研究,预计到2050 年,全球约有10 亿人患有骨关节炎,而根据《柳叶刀风湿病学》杂誌的数据,到2023 年,全球30 岁或以上人口中约有15% 患有骨关节炎。
人们越来越多地采取积极主动的措施来支持他们的整体健康,包括使用促进骨骼和关节健康的补充剂。随着健身趋势的不断发展以及对保持积极生活方式的关注,消费者正在寻求含有钙、维生素 D 和 omega-3 脂肪酸等关键成分的产品,以增强骨骼强度和灵活性。
整个骨关节保健品产业根据产品、形式、消费者、配销通路和地区进行细分。
Omega-3 脂肪酸部分预计到 2032 年将大幅成长,因为它们具有抗发炎特性,可以缓解关节疼痛。鱼油中含有的这些必需脂肪酸有助于维持最佳骨密度。消费者越来越重视自然的医疗保健方法,有利于该细分市场的成长。
由于生物利用度,预计粉末细分市场在 2023 年和 2032 年将出现显着的CAGR。与传统的药丸或胶囊不同,粉末状补充剂可以快速吸收,使身体能够利用必需的营养素。此外,粉末形式在剂量定制方面提供了更大的灵活性,使消费者能够根据个人需求轻鬆调整摄取量。
受阿育吠陀和传统中医等传统疗法的青睐,亚太地区骨关节保健品市占率将在 2023 年至 2032 年间大幅成长。在印度和中国等国家,久坐的生活方式和城市化日益盛行,导致肌肉骨骼问题的发生率增加,从而产生了对解决这些问题的补充剂的需求。采用创新配方,将古老方法与现代营养科学结合,进一步刺激了区域产业的成长。
Bone & Joint Health Supplements Industry is projected to grow at a CAGR of 7.5% from 2024 to 2032, driven by aging population. There is a rising prevalence of bone and joint-related issues, such as osteoporosis and arthritis. According to Lancet study, around one billion people globally are estimated to suffer from osteoarthritis by 2050, and as per the Lancet Rheumatology journal, around 15% of the global population aged 30 years or above had osteoarthritis in 2023.
People are increasingly adopting proactive measures to support their overall well-being, including the use of supplements that promote bone and joint health. With growing fitness trends and a focus on maintaining an active lifestyle, consumers are seeking products containing key ingredients such as calcium, vitamin D, and omega-3 fatty acids to enhance bone strength and flexibility.
The overall bone & joint health supplements industry is segmented on the basis of product, form, consumer, distribution channel, and region.
Omega-3 fatty acid segment is anticipated to witness substantial growth through 2032, as they exhibit anti-inflammatory properties that can alleviate joint pain. These essential fatty acids, found in fish oil, help in maintaining optimal bone density. The consumers are increasingly prioritizing natural approaches to healthcare, favoring the segment growth.
Powder segment is expected to observe a significant CAGR during 2023 and 2032, attributed to the bioavailability. Unlike traditional pills or capsules, powdered supplements can be quickly absorbed, allowing the body to utilize the essential nutrients. Additionally, the powder format provides greater flexibility in dosage customization, enabling consumers to easily adjust their intake based on individual needs.
Asia Pacific bone & joint health supplements market share will grow substantially between 2023 and 2032, favored by the emphasis on traditional practices such as ayurveda and traditional chinese medicine. The rising prevalence of sedentary lifestyle and urbanization in countries such as India and China has resulted in an increased rate of musculoskeletal issues, creating a demand for supplements that address these concerns. The adoption of innovative formulations, blending ancient methods with modern nutritional science, further stimulates the regional industry growth.